Prophylactic defibrillator after the MADIT II study - The glimpse of a turning point? Foreword

被引：0
|
作者：
Touboul, P [1 ]
机构：
[1] Hop Cardiovasc & Pneumol Louis Pradel, Serv Cardiol, F-69500 Bron, France
来源：
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 2003年 / 96卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：277 / 280
页数：4
相关论文
共 13 条
  • [1] Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Madit-II trial
    Goldenberg, I
    Hall, JW
    McNitt, S
    Zareba, W
    Andrews, ML
    Cannom, DS
    Moss, AJ
    CIRCULATION, 2005, 112 (17) : U592 - U592
  • [2] Reduced pumping action after myocardial infarction - Indication for defibrillator implant? - The MADIT II study
    Borggrefe, M
    INTERNIST, 2003, 44 (01): : 110 - 112
  • [3] Time dependence of defibrillator benefit after coronary revascularization in the multicenter automatic defibrillator implantation trial (MADIT)-II
    Goldenberg, I
    Moss, AJ
    McNitt, S
    Zareba, W
    Hafl, WJ
    Andrews, ML
    Wilber, DJ
    Klein, HU
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1811 - 1817
  • [4] Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II
    Goldenberg, I
    Moss, AJ
    Hall, J
    McNitt, S
    Zareba, W
    Andrews, ML
    Cannom, DS
    CIRCULATION, 2006, 113 (24) : 2810 - 2817
  • [5] Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study
    Cappato, Riccardo
    Zanotto, Gabriele
    Menozzi, Carlo
    Coppola, Antonio
    Curnis, Antonio
    Freggiaro, Valerio
    Sanna, Tommaso
    Sinagra, Gianfranco
    Pizzetti, Fabrizio
    Sermasi, Sergio
    Locatelli, Alessandro
    Zaccone, Gabriele
    Pecora, Domenico
    Raciti, Giovanni
    Accardi, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 268 - 269
  • [6] Prevalence of patients with MUSTT and MADIT II indications for prophylactic implantable cardioverter-defribrillator treatment after myocardial infarction
    Huikuri, HV
    Raatikainen, MJ
    Mahaux, V
    Bloch-Thomsen, PE
    EUROPEAN HEART JOURNAL, 2003, 24 : 373 - 373
  • [7] Low rate of prophylactic ICD-implantation in real life 2 years after MADIT II - the German situation unmasked by the prevention of sudden cardiac death II registry
    Voeller, H.
    Block, M.
    Klein, H.
    Kamke, W.
    Fetsch, T.
    Suciu, A.
    Contzen, K.
    EUROPEAN HEART JOURNAL, 2005, 26 : 428 - 428
  • [8] Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study
    Mueller-Leisse, Johanna
    Brunn, Johanna
    Zormpas, Christos
    Hohmann, Stephan
    Hillmann, Henrike Aenne Katrin
    Eiringhaus, Joerg
    Bauersachs, Johann
    Veltmann, Christian
    Duncker, David
    ESC HEART FAILURE, 2022, 8 (06): : 5142 - 5148
  • [9] Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study
    Mueller-Leisse, Johanna
    Brunn, Johanna
    Zormpas, Christos
    Hohmann, Stephan
    Hillmann, Henrike Aenne Katrin
    Eiringhaus, Joerg
    Bauersachs, Johann
    Veltmann, Christian
    Duncker, David
    ESC HEART FAILURE, 2021, 8 (06): : 5142 - 5148
  • [10] The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results
    Mebus, Siegrun
    Schulze-Neick, Ingram
    Oechslin, Erwin
    Niwa, Koichiro
    Trindade, Pedro T.
    Eicken, Andreas
    Hager, Alfred
    Lang, Irene
    Hess, John
    Kaemmerer, Harald
    CURRENT CARDIOLOGY REVIEWS, 2010, 6 (04) : 356 - 362
12